Many hospital pharmacies are reluctant to store admixed parenteral fluids longer than 24 to 48 h because of concern about possible microbial contamination. We evaluated the safety of prolonged refrigerated storage of admixtures by culturing mixtures in 471 bags prepared routinely in a hospital pharmacy and stored at 4°C for up to 15 days. Low-level contamination (1 CFU per bag) was found in 3 of 253 solutions of saline and/or glucose into which nonantibiotic additives had been injected. None of 171 saline and/or glucose solutions with antibiotic additives or 47 parenteral nutrition fluids was culture positive. The risk of contamination did not increase with duration of storage, and none of 107 bags stored .5 days was culture positive. Laboratory studies to measure growth of bacteria and fungi in glucose infusate and parenteral nutrition solutions confirmed that storage at 4°C suppresses growth. Eight of twelve bacterial isolates grew in glucose solutions at 25°C, while none grew at 4°C. Of 13 species of bacteria and fungi inoculated in parenteral nutrition fluids, 8 proliferated at 25°C and none proliferated at 4°C. We conclude that refrigerated storage of parenteral fluids for up to 1 week following admixture, as permitted by Centers for Disease Control guidelines, does not appear to increase the risk of microbial contamination when standard aseptic procedures for admixing and storage are followed.
When patient orders are changed after intravenous (i. v.) admixtures have been prepared, the hospital pharmacy may be left with admixed fluids that cannot be used immediately. Concern about possible microbial contamination during admixing has made many pharmacies reluctant to store these admixed i.v. fluids for later use. Although guidelines issued by the Centers for Disease Control have sanctioned refrigerated storage for up to 1 week (27) , the absence of studies documenting sterility of stored admixtures has made some hospitals unwilling to extend refrigerated storage time of admixed stable compounds this long.
To assess the safety of prolonged refrigerated storage, we tested the sterility of 471 bags of admixed fluids stored at 4°C for up to 15 days. We also investigated the potential consequences of contamination by seeding i.v. fluids with organisms that have been reported to proliferate in these fluids (2, 4, 6, 9-12, 17, 23 in saline. A sample of 0.1 ml of each strain was inoculated into each of three bags or bottles containing 100 ml of the fluid to be tested, to give an initial concentration of about 1 CFU/ml. Samples of bacterial and yeast suspensions were also inoculated into Trypticase soy broth or Sabouraud broth as positive controls for growth.
Immediately after inoculation, 20 ml of fluid was removed and passed through a 0.45-,um-pore-size filter (Millipore Corp., Bedford, Mass.). Filters were placed on CBA or Sabouraud agar and incubated at 35 or 25°C for bacteria or yeasts, respectively. Colony counts were made after a period of incubation appropriate for the organism being studied.
Inoculated fluids were incubated as follows: one bag or bottle containing each strain was kept at room temperature (250C), one was refrigerated (4 to 5°C) continuously, and one was refrigerated intermittently, i.e., 18 h of refrigeration, then 6 h at 25°C, followed by refrigeration for the remainder of the test period. The last pattern was intended to simulate poor handling conditions under which fluids sent to patient units might remain out at room temperature for as long as 6 h.
Inoculated fluids were sampled after 24, 48, 72, and 96 h and 1 week of incubation. A 20-ml sample and a 0.1-ml sample were taken from each fluid from which little growth was expected. The 0.1-ml sample was plated directly on CBA or Sabouraud agar, and the 20-ml sample was passed through a 0.45-,um-pore-size filter, which was then placed on CBA or Sabouraud agar. Samples drawn from other fluids were serially diluted 10-fold in saline, and 0. Growth of all 12 isolates also was tested under simulated in-use conditions in which inoculated infusates were allowed to stand at 25°C for 6 h after an initial 18 h of refrigerated storage. Results of these simulation studies were the same as for infusate solutions stored continuously at 4°C.
Growth of 13 species of bacteria and fungi was tested in parenteral nutrition solutions containing 10% glucose plus 2.1% crystalline amino acids (bacteria) or 20% glucose plus 4.25% crystalline amino acids (fungi). Eight of the organisms proliferated at 25 but not at 4°C (Table 3) . None of the other five organisms (E. agglomerans, C. freundii, P. aeruginosa, P. fluorescens, or A. calcoaceticus var. anitratus) grew at 4 or 25°C. Results of simulation studies in which refrigeration was interrupted for 6 h were the same as those for continuous storage at 4°C.
Survey of hospital pharmacies. Storage time for i.v. admixtures and parenteral nutrition solutions was reported by all 25 Chicago hospitals with a bed capacity exceeding 300. Only eight hospitals permitted refrigerated storage of admixtures for more than 2 days (Table 4) .
DISCUSSION
The potential for glucose-containing i.v. fluids to become heavily contaminated by bacteria has been established by clinical experience and laboratory studies. A nationwide epidemic of infusion sepsis in 1970 and 1971 generated widespread awareness of this hazard and focused attention on the manufacturing process (10, 18) . Investigations of other epidemics have shown that contamination also can occur during admixture or administration of infusate (5, 7, 8, 24, 28) . Bacteria implicated in these epidemics have been primarily members of the tribe Klebsielleae. These organisms, which commonly can be isolated from the hands and nares of pharmacy personnel (30) , replicate rapidly enough in glucose infusate at incubator (2) or room (17) temperature to increase their concentration 1,000-to 100,000-fold within 24 h.
Parenteral nutrition fluids potentially pose even greater risks than glucose solutions, because some components can support the growth of a broader range of bacteria and fungi. In particular, lipid emulsions provide an excellent medium for many organisms (20) and have been implicated in cases of sepsis (14, 23) . Formulations containing hypertonic glucose plus casein hydrolysate as a protein source provide substrates for Candida species (6, 9, 11, 12) and for a variety of bacteria, including E. coli, K. pneumoniae, Serratia marcescens, P. aeruginosa, and Staphylococcus aureus (6, 9, 12) . Crystalline amino acids, which were used in the present study and which have largely replaced casein hydrolysate, support the growth of Candida species but not bacteria (4, 9, 11, 12) . Recognition of the potentially serious consequences of microbial contamination prompted widespread adoption of infection control guidelines for admixing and administering i.v. solutions (27, 29) . Observance of these guidelines has been associated with low rates of contamination, usually in the range of 0 to 1% (1, 16, 19, 25) . Higher rates of contamination occasionally have been reported but may be due to contamination of specimens during testing. Several studies showing higher rates also revealed contamination rates of 1 to 8% in control solutions which had not been admixed (3, 13, 26) .
In the present study, the rate of positive cultures from stored admixed fluids was 0.64% overall and 1.0% (3 of 300) from bags with nonantibiotic additives. Because only a single colony grew from each culture-positive bag, the possibility that contamination occurred during manipulation for culturing could not be excluded. Even if all of the positive cultures represent contamination during admixture, the low rate of positive cultures and the extremely low number of organisms per culture-positive bag indicate that refrigerated storage of admixed parenteral fluids for up to 1 week should be safe.
Findings from the growth studies reported herein provide (27) . Waste of i.v. admixtures was not tabulated as part of the present study, but in another study, outdating, often at 48 h was a major cause of pharmacy waste (21) . As of 1986, the Centers for Disease Control recommendation had not been implemented at the hospital where this study was performed or at most other hospitals in Chicago. Our findings indicate that cost savings achievable by refrigerator storage of admixed fluids for up to 1 week should be realized without a predictable increase in infection risk.
